6505--Prednisolone 1% Ophthalmic Solution

The Department of Veterans Affairs National Acquisition Center seeks offers for Prednisolone Acetate 1% Ophthalmic Suspension across three line items in multiple package sizes, with proposals due October 14, 2026, at 2:30 PM Central Time. This is an unrestricted acquisition.

Estimated annual volumes are 392,107 units of 5ML bottles, 70,070 units of 10ML bottles, and 10,172 units of 15ML bottles. The contract structure includes a one-year base ordering period plus four one-year optional ordering periods, with implementation not to exceed 60 days.

Distribution scope encompasses all VA facilities, DoD Ordering Activities, Indian Health Service facilities, Bureau of Prisons facilities, the Captain James A. Lovell Federal Health Care Center, and State Veterans Homes under Option 2.

Offerors must submit prices for all line items for both the base year and all four option years to be considered for award. All proposed prices must include a 0.5% Cost Recovery Fee and must not exceed two decimal places. Offerors must provide an 11-digit National Drug Code unique to their company, meet current Good Manufacturing Practices standards with FDA-acceptable facility status, comply with Drug Supply Chain Security Act requirements including serialized transaction information and NABP Trading Partner Directory registration, and include barcode labeling meeting GS1-128 or HIBCC standards. Offerors that are not manufacturers must submit a Letter of Commitment from the manufacturer. If offering a covered drug under 38 U.S.C. 8126, offerors must have an executed Master Agreement and Pharmaceutical Pricing Agreement with VA's Federal Supply Schedule. The NAICS code is 325412, Pharmaceutical Preparation Manufacturing, and the PSC is 6505, Drugs And Biologicals. Proposals must be submitted via email in Microsoft Word or PDF format with a signed SF-1449.